FDA Approves Ritedose's Albuterol Sulfate Inhalation Solution Amid National Shortage
Ritedose Pharmaceuticals has received FDA approval for Albuterol Sulfate Inhalation Solution 0.5% (2.5 mg/0.5 mL), completing their portfolio of albuterol treatments amid a nationwide shortage that has persisted since October 2022.